153 related articles for article (PubMed ID: 27079868)
21. Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo.
Juengel E; Makarević J; Tsaur I; Bartsch G; Nelson K; Haferkamp A; Blaheta RA
PLoS One; 2013; 8(1):e53100. PubMed ID: 23372654
[TBL] [Abstract][Full Text] [Related]
22. Butanol fraction of Khaya senegalensis root modulates β-cell function and ameliorates diabetes-related biochemical parameters in a type 2 diabetes rat model.
Ibrahim MA; Islam MS
J Ethnopharmacol; 2014 Jul; 154(3):832-8. PubMed ID: 24846204
[TBL] [Abstract][Full Text] [Related]
23. Novel Pentapeptide GLP-1 (32-36) Amide Inhibits β-Cell Apoptosis In Vitro and Improves Glucose Disposal in Streptozotocin-Induced Diabetic Mice.
Sun L; Dai Y; Wang C; Chu Y; Su X; Yang J; Zhou J; Huang W; Qian H
Chem Biol Drug Des; 2015 Dec; 86(6):1482-90. PubMed ID: 26178446
[TBL] [Abstract][Full Text] [Related]
24. Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic β cells.
Liu S; Du F; Li X; Wang M; Duan R; Zhang J; Wu Y; Zhang Q
PLoS One; 2017; 12(4):e0175498. PubMed ID: 28394923
[TBL] [Abstract][Full Text] [Related]
25. Early Treatment with Empagliflozin and GABA Improves
Daems C; Welsch S; Boughaleb H; Vanderroost J; Robert A; Sokal E; Lysy PA
J Diabetes Res; 2019; 2019():2813489. PubMed ID: 31467926
[TBL] [Abstract][Full Text] [Related]
26. Proposed mechanisms for oligonucleotide IMT504 induced diabetes reversion in a mouse model of immunodependent diabetes.
Bianchi MS; Bianchi S; Hernado-Insúa A; Martinez LM; Lago N; Libertun C; Chasseing NA; Montaner AD; Lux-Lantos VA
Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E380-95. PubMed ID: 27329801
[TBL] [Abstract][Full Text] [Related]
27. Effect of Silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model.
Soto C; Raya L; Juárez J; Pérez J; González I
Phytomedicine; 2014 Feb; 21(3):233-9. PubMed ID: 24176839
[TBL] [Abstract][Full Text] [Related]
28. A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats.
Akarte AS; Srinivasan BP; Gandhi S
Biochem Pharmacol; 2012 Jan; 83(2):241-52. PubMed ID: 22015634
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
[TBL] [Abstract][Full Text] [Related]
30. Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats.
Cho HM; Seok YM; Lee HA; Song M; Kim I
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424007
[TBL] [Abstract][Full Text] [Related]
31. HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells.
Ganai SA; Kalladi SM; Mahadevan V
J Biomol Struct Dyn; 2015; 33(6):1185-97. PubMed ID: 25012937
[TBL] [Abstract][Full Text] [Related]
32. Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.
Sun L; Qian Q; Sun G; Mackey LV; Fuselier JA; Coy DH; Yu CY
J Drug Target; 2016; 24(2):169-77. PubMed ID: 26211366
[TBL] [Abstract][Full Text] [Related]
33. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation.
Zhang Z; Qin X; Tong N; Zhao X; Gong Y; Shi Y; Wu X
Exp Eye Res; 2012 Jan; 94(1):98-108. PubMed ID: 22143029
[TBL] [Abstract][Full Text] [Related]
34. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
35. Biochemical efficacy of vitamin D in ameliorating endocrine and metabolic disorders in diabetic rats.
Sadek KM; Shaheen H
Pharm Biol; 2014 May; 52(5):591-6. PubMed ID: 24251869
[TBL] [Abstract][Full Text] [Related]
36. Hidden pharmacological activities of valproic acid: A new insight.
Singh D; Gupta S; Verma I; Morsy MA; Nair AB; Ahmed AF
Biomed Pharmacother; 2021 Oct; 142():112021. PubMed ID: 34463268
[TBL] [Abstract][Full Text] [Related]
37. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model.
Feng D; Wu J; Tian Y; Zhou H; Zhou Y; Hu W; Zhao W; Wei H; Ling B; Ma C
PLoS One; 2013; 8(11):e80657. PubMed ID: 24260446
[TBL] [Abstract][Full Text] [Related]
38. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats.
Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA
J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496
[TBL] [Abstract][Full Text] [Related]
39. A bio-inspired injectable hydrogel as a cell platform for real-time glycaemic regulation.
Zhang Y; Yang J; Zhang J; Li S; Zheng L; Zhang Y; Meng H; Zhang X; Wu Z
J Mater Chem B; 2020 Jun; 8(21):4627-4641. PubMed ID: 32373901
[TBL] [Abstract][Full Text] [Related]
40. Modulatory effect of garcinol in streptozotocin-induced diabetic Wistar rats.
Madhuri K; Naik PR
Arch Physiol Biochem; 2017 Dec; 123(5):322-329. PubMed ID: 28598692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
